IPSC — Century Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1850119 ·
Last close
$1.37
Market Cap
$248.79M
52W High
$3.04
52W Low
$0.45
ADV30
930,732
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -25,206,000 | -23,453,000 | 262,626,000 | 45,016,000 | 52,659,000 |
| Jun 2026 | 0 | — | -25,382,000 | -34,550,000 | 287,006,000 | 49,642,000 | 54,661,000 |
| Mar 2026 | 0 | — | -23,684,000 | -21,645,000 | 326,553,000 | 51,048,000 | 61,809,000 |
| Dec 2025 | 0 | — | -20,651,000 | -19,171,000 | 223,704,000 | 61,853,000 | 64,768,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,401,000
Investing CF
$-54,961,000
Financing CF
$127,063,000
CapEx
$-2,008,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.79
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-871,565,000
Inventory
—
Receivables
$667,000
ST Investments
$72,185,000
EBIT TTM
$-94,923,000
Pretax Income TTM
$-98,887,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-92,245,000
Free Cash Flow
$-57,537,376
Enterprise Value
$219,926,048
Total Cash
$117,201,000
Total Debt
$37,492,000
Shares Out
181,597,002
Trailing EPS
$-0.64
Book Value
$1.16
ROE
-51.2%
ROA
-25.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 109,164,000 | -10,506,000 | -9,580,000 | 223,704,000 | 64,768,000 | 158,936,000 | -103,876,000 |
| Dec 2024 | 6,589,000 | -133,810,000 | -126,566,000 | 353,216,000 | 191,854,000 | 161,362,000 | -110,135,000 |
| Dec 2023 | 2,235,000 | -125,181,000 | -136,673,000 | 360,691,000 | 175,941,000 | 184,750,000 | -88,348,000 |
| Dec 2022 | 5,199,000 | -123,831,000 | -130,932,000 | 486,544,000 | 183,806,000 | 302,738,000 | 14,052,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-109,794,000
OpCashFlow TTM
—
Assets (Latest)
$287,006,000
Forward EPS
$-0.45
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | $242.84M | $2.88 | — |
| OCGN | Ocugen, Inc. | $256.75M | $0.76 | — |
| ALLO | Allogene Therapeutics, Inc. | $257.08M | $0.74 | — |
| LXEO | Lexeo Therapeutics, Inc. | $234.24M | $2.86 | — |
| SABS | SAB Biotherapeutics, Inc. | $265.76M | $2.95 | — |
News headlines (Yahoo Finance, 1h cache)
Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
2026-11-12 12:05 · Yahoo
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
2026-10-14 12:05 · Yahoo
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
2026-10-02 12:05 · Yahoo
Century Therapeutics Appoints Joseph Truitt to Board of Directors
2026-09-09 20:05 · Yahoo
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
2026-08-12 12:00 · Yahoo
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses
2026-07-14 10:33 · Yahoo
Century Therapeutics Reports First Quarter Financial Results and Business Updates
2026-05-13 12:00 · Yahoo
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
2026-04-30 20:05 · Yahoo
Here's Why We're Watching Century Therapeutics' (NASDAQ:IPSC) Cash Burn Situation
2026-06-13 13:38 · Yahoo
H.C. Wainwright Remains Bullish on Century Therapeutics (IPSC)
2026-05-01 08:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.